Amneal Pharmaceuticals, Inc. Class A Common Stock (NYSE:AMRX)
8.405 USD
-0.005 0.060%Previous Close (in USD) | 8.41 |
---|---|
Change | -0.005 0.060% |
52 W H/L (in USD) | 9.475/4.460 |
EBITDA (in USD) | 566.76M |
PE Ratio | -- |
Volume | 421792 |
Diluted Eps TTM | -0.86 |
Total Assets (in USD) | 3472.569M |
---|---|
Total Liabilities (in USD) | 3452.788M |
Revenue TTM (in USD) | 2680.42M |
Cash (in USD) | 91.542M |
Market Cap (in USD) | 3,764.982 M |
Revenue Per Share TTM | 9.160 |
Gross Profit TTM (in USD) | 791.461M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Amneal Pharmaceuticals, Inc. Class A Common Stock
Employees: 7850
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. Chirag K. Patel | Co-Founder, Co-CEO, Pres & Director | 1967 |
2. | Mr. Chintu Patel R.Ph, R.Ph. | Co-Founder, Co-CEO & Director | 1972 |
3. | Mr. Anastasios G. Konidaris | Exec. VP & CFO | 1967 |
4. | Ms. Nikita Shah | Exec. VP and Chief HR & Strategic Planning Officer | 1978 |
5. | Mr. Andrew S. Boyer | Exec. VP & Chief Commercial Officer of Generics | 1966 |
6. | Mr. Anthony DiMeo | Sr. Director of Investor Relations | NA |
7. | Mr. Jason B. Daly Esq. | Sr. VP, Chief Legal Officer & Corp. Sec. | 1974 |
8. | Mr. Sanjiv Patel | Sr. VP of Operations | NA |
9. | Dr. Nikunj Patel | Head of Ops & Exec. VP of Amneal Pharmaceuticals (India) Pvt Ltd | NA |
10. | Mr. Sanjay Kumar Jain Ph.D. | Pres of India Operations | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
ZTS
Zoetis Inc |
+1.310 0.834% | 156.76 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
MKKGY
Merck KGaA ADR |
+0.610 2.382% | 25.94 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
0.000 0.000% | 129.3 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
TAK
Takeda Pharmaceutical Co Ltd ADR |
-0.025 0.166% | 15.03 | 32.670 | 11.534 | 0.011 | 0.874 | 0.018 | 0.069 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | -248.127M | 31.366M | -35.78M | -220.242M | -202.722M |
Minority Interest | -125.241M | 9.546M | -22.481M | 114.778M | 391.613M |
Net Income | -254.789M | 20.17M | 68.578M | -603.573M | -169.726M |
Selling General Administrative | 400.431M | 365.704M | 326.727M | 289.598M | 230.435M |
Gross Profit | 784.708M | 768.973M | 628.393M | 352.997M | 716.403M |
Reconciled Depreciation | 240.175M | 233.406M | 235.387M | 207.235M | 137.403M |
Ebit | 206.464M | 209.236M | 91.155M | -137.423M | 278.365M |
Ebitda | 446.639M | 442.642M | 349.058M | 69.812M | 415.768M |
Depreciation And Amortization | 240.175M | 233.406M | 257.903M | 207.235M | 137.403M |
Operating Income | 206.464M | 209.236M | 91.155M | -137.423M | -19.673M |
Other Operating Expenses | 2023.382M | 1899.763M | 1881.442M | 1765.261M | 1387.474M |
Interest Expense | 158.377M | 136.325M | 145.998M | 168.205M | 143.571M |
Tax Provision | 6.662M | 11.196M | -104.358M | 383.331M | -1.419M |
Interest Income | - | - | - | 173.167M | 163.272M |
Net Interest Income | -158.668M | -136.325M | -145.998M | -168.205M | -143.571M |
Income Tax Expense | 6.662M | 11.196M | -104.358M | 383.331M | -1.419M |
Total Revenue | 2212.304M | 2093.669M | 1992.523M | 1626.373M | 1662.991M |
Total Operating Expenses | 595.786M | 575.067M | 517.312M | 491.885M | 440.886M |
Cost Of Revenue | 1427.596M | 1324.696M | 1364.13M | 1273.376M | 946.588M |
Total Other Income Expense Net | -454.591M | -177.87M | -126.935M | -82.819M | -334.668M |
Net Income From Continuing Ops | -254.789M | 20.17M | 68.578M | -603.573M | -201.303M |
Net Income Applicable To Common Shares | -129.986M | 10.624M | 91.059M | -361.917M | -20.92M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Total Assets | 3472.569M | 3799.341M | 3939.664M | 4006.033M | 3665.89M |
Intangible Assets | 890.423M | 1096.093M | 1166.922M | 1304.626M | 1382.753M |
Other Current Assets | 91.205M | 103.565M | 110.218M | 73.467M | 70.164M |
Total Liab | 3452.788M | 3590.413M | 3572.691M | 3661.101M | 3319.102M |
Total Stockholder Equity | 19.781M | 183.979M | 366.973M | 344.932M | 346.788M |
Other Current Liab | 475.399M | 109.962M | 47.861M | 7.561M | 5.969M |
Common Stock | 3.066M | 3.036M | 3.014M | 2.997M | 2.992M |
Capital Stock | 3.066M | 3.036M | 3.014M | 2.997M | 2.992M |
Retained Earnings | -490.176M | -406.183M | -276.197M | -286.821M | -377.88M |
Good Will | 598.629M | 598.853M | 593.017M | 522.814M | 419.504M |
Other Assets | - | 17.631M | 473.696M | 149.3M | 16.455M |
Cash | 91.542M | 25.976M | 247.79M | 341.378M | 151.197M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 846.595M | 752.8M | 677.243M | 676.902M | 550.406M |
Current Deferred Revenue | 398.411M | - | - | - | - |
Net Debt | 2658.981M | 2819.159M | 2628.266M | 2599.43M | 2614.87M |
Short Term Debt | 227.624M | 104.639M | 46.037M | 55.68M | 36.954M |
Short Long Term Debt | 213.125M | 89.961M | 30.614M | 45.228M | 21.479M |
Short Long Term Debt Total | 2750.523M | 2845.135M | 2876.056M | 2940.808M | 2766.067M |
Other Stockholder Equity | 539.24M | 577.187M | 664.983M | 670.074M | 721.744M |
Property Plant Equipment | - | 469.815M | 514.158M | 477.754M | 620.595M |
Total Current Assets | 1377.863M | 1411.818M | 1520.108M | 1551.539M | 1210.21M |
Long Term Investments | - | - | - | - | 16.373M |
Short Term Investments | 2.2M | - | - | - | 1.123M |
Net Receivables | 613.732M | 742.291M | 663.762M | 640.302M | 606.157M |
Long Term Debt | 2427.451M | 2591.981M | 2680.053M | 2735.264M | 2609.046M |
Inventory | 581.384M | 530.735M | 489.389M | 490.649M | 381.067M |
Accounts Payable | 143.572M | 538.199M | 583.345M | 613.661M | 507.483M |
Accumulated Other Comprehensive Income | -32.349M | 9.939M | -24.827M | -41.318M | -0.068M |
Non Currrent Assets Other | 18.428M | 103.217M | 20.614M | 31.885M | 44.27M |
Non Current Assets Total | 2094.706M | 2387.523M | 2419.556M | 2454.494M | 2455.68M |
Capital Lease Obligations | 109.947M | 123.487M | 127.351M | 123.876M | 135.542M |
Long Term Debt Total | - | 2591.981M | 2680.053M | 2735.264M | 2674.509M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -174.309M | -194.182M | -317.546M | -19.58M | -396.378M |
Total Cashflows From Investing Activities | -174.309M | -194.182M | -317.546M | -19.58M | -396.378M |
Total Cash From Financing Activities | -106.62M | -138.122M | 131.807M | -45.833M | 287.675M |
Net Income | -254.789M | 20.17M | 68.578M | -603.573M | -201.303M |
Change In Cash | -221.512M | -90.382M | 194.299M | -65.957M | 140.857M |
Begin Period Cash Flow | 256.739M | 347.121M | 152.822M | 218.779M | 77.922M |
End Period Cash Flow | 35.227M | 256.739M | 347.121M | 152.822M | 218.779M |
Total Cash From Operating Activities | 65.1M | 241.82M | 379.001M | 1.705M | 250.23M |
Depreciation | 240.175M | 233.406M | 235.387M | 207.235M | 137.403M |
Other Cashflows From Investing Activities | -127.902M | -146.454M | -261.101M | 27.601M | -313.29M |
Dividends Paid | - | - | - | 0M | 182.998M |
Change To Inventory | -102.396M | -49.015M | -113.782M | -20.393M | -42.875M |
Sale Purchase Of Stock | -1.06M | 0.853M | 0.321M | 1.4M | -7.618M |
Other Cashflows From Financing Activities | 15.99M | -58.943M | 168.819M | -16.563M | 1255.009M |
Capital Expenditures | 90.595M | 52.639M | 66.186M | 97.431M | 97.088M |
Change In Working Capital | -59.945M | -133.593M | -61.318M | -120.217M | 7.01M |
Other Non Cash Items | 107.812M | 10.036M | 19.96M | 124.865M | 148.962M |
Free Cash Flow | -25.495M | 189.181M | 312.815M | -95.726M | 153.142M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | iShares Russell 2000 ETF | 7 months ago | 4508577 |
2. | Vanguard Total Stock Mkt Idx Inv | 8 months ago | 4364427 |
3. | Vanguard Small Cap Index | 8 months ago | 3498775 |
4. | Vanguard Small Cap Value Index Inv | 8 months ago | 2360216 |
5. | Vanguard Institutional Extnd Mkt Idx Tr | 8 months ago | 2155080 |
6. | Fidelity Small Cap Index | 9 months ago | 1615726 |
7. | Hennessy Cornerstone Growth Investor | 9 months ago | 1564000 |
8. | CREF Stock R1 | 10 months ago | 1314150 |
9. | iShares Russell 2000 Growth ETF | 7 months ago | 1209998 |
10. | Columbia Small Cap Value II Inst | 8 months ago | 1173930 |
11. | Columbia Small Cap Value II | 9 months ago | 1173930 |
12. | Invesco Pharmaceuticals ETF | 7 months ago | 1085362 |
13. | Neuberger Berman Intrinsic Value I | 8 months ago | 1056854 |
14. | Nuveen Quant Small Cap Equity R6 | 9 months ago | 1036190 |
15. | Phocas Small Cap Value Equity | 1 year ago | 936264 |
16. | State St Russell Sm/Mid Cp® Indx NL Cl C | 8 months ago | 902381 |
17. | DFA US Small Cap I | 8 months ago | 863160 |
18. | Fidelity Extended Market Index | 8 months ago | 816867 |
19. | Dimensional US Small Cap ETF | 7 months ago | 773920 |
20. | Invesco Dorsey Wright SmallCap Momt ETF | 7 months ago | 755825 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | UBS Group AG | 9 months ago | 21773049 |
2. | Vanguard Group Inc | 9 months ago | 14623944 |
3. | TPG GP A, LLC | 9 months ago | 12328767 |
4. | BlackRock Inc | 1 year ago | 11282430 |
5. | Rubric Capital Management LP | 9 months ago | 10721778 |
6. | Citadel Advisors Llc | 9 months ago | 8892293 |
7. | Dimensional Fund Advisors, Inc. | 9 months ago | 4713049 |
8. | Neuberger Berman Group LLC | 9 months ago | 3787665 |
9. | Geode Capital Management, LLC | 9 months ago | 3786671 |
10. | State Street Corp | 9 months ago | 3514721 |
11. | Nuveen Asset Management, LLC | 9 months ago | 2920579 |
12. | Nantahala Capital Management, LLC | 9 months ago | 2669943 |
13. | BlackBarn Capital Partners LP | 9 months ago | 2411612 |
14. | Amvescap Plc. | 9 months ago | 2297197 |
15. | Arrowstreet Capital Limited Partnership | 9 months ago | 2068979 |
16. | Fosun International Ltd | 9 months ago | 1720855 |
17. | Northern Trust Corp | 9 months ago | 1620584 |
18. | Woodline Partners LP | 9 months ago | 1604531 |
19. | Ameriprise Financial Inc | 9 months ago | 1588368 |
20. | Hennessy Advisors, Inc. | 9 months ago | 1564000 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).